Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | CPT1A | P50416 | 6/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | VDR | P11473 | 4/20 | 0.45 |
| ▸ | NR1H4 | Q96RI1 | 4/20 | 0.45 |
| ▸ | CPT1B | Q92523 | 4/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.44 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.44 |
| ▸ | CPT2 | P23786 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5511460 | 0.92 | L3MBTL1 (0.48) | L3MBTL1CPT1AACHEALDH1A1LMNA | |
| SCHEMBL4131668 | 0.89 | L3MBTL1 (0.45) | L3MBTL1CPT1AACHEALDH1A1LMNA | |
| SCHEMBL5515105 | 0.85 | L3MBTL1 (0.48) | L3MBTL1CPT1AACHEALDH1A1LMNA | |
| SCHEMBL14613989 | 0.85 | CYP2D6 (0.45) | L3MBTL1CPT1AACHEALDH1A1LMNA | |
| SCHEMBL5514473 | 0.84 | L3MBTL1 (0.56) | L3MBTL1VDRNR1H4 | |
| SCHEMBL14382778 | 0.83 | OPRM1 (0.56) | L3MBTL1VDRNR1H4OPRM1OPRD1 | |
| SCHEMBL13904453 | 0.83 | L3MBTL1 (0.43) | L3MBTL1CPT1AACHEALDH1A1LMNA | |
| SCHEMBL5511472 | 0.82 | L3MBTL1 (0.52) | L3MBTL1CPT1AVDRNR1H4CPT1B | |
| SCHEMBL27574019 | 0.82 | L3MBTL1 (0.69) | L3MBTL1OPRM1OPRD1OPRK1 | |
| SCHEMBL28746776 | 0.81 | L3MBTL1 (0.58) | L3MBTL1VDRNR1H4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6770666-B2 | A THERAPEUTIC AGENT FOR TREATING HEPATITIS C, BASED ON POLYMERASE INHIBITORY ACTIVITY | JAPAN TOBACCO INC. (JP) | 2004-08-03 | — | — | US | disclosed |
| US-20030050320-A1 | Fused-ring compounds and use thereof as drugs | JAPAN TOBACCO INC. (JP) | 2003-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030050320-A1 | Fused-ring compounds and use thereof as drugs | HAVCR2, ZC3HAV1, HLA-C | L3MBTL1 4672/4885CPT1A 307/4885ACHE 4160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.